Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Medroxyprogesterone Acetate × Clear all

Phase

Status

Completed 8 Recruiting 6 Terminated 2 Not yet recruiting 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Endometrial Neoplasms 1

Interventions

pembrolizumab 380 Carboplatin 270 Cyclophosphamide 265 Nivolumab 260 Specimen Handling 215 Paclitaxel 215 Magnetic Resonance Spectroscopy 212 Cisplatin 207 Radiotherapy 191 Dexamethasone 161 Gemcitabine 157 durvalumab 154 Biopsy 148 atezolizumab 137 Lenalidomide 127 Doxorubicin 120 Rituximab 118 Bevacizumab 118 Docetaxel 116 Ipilimumab 115 Oxaliplatin 104 Capecitabine 104 Radiosurgery 101 Radiation 100 Fluorouracil 100 fludarabine 98 Etoposide 95 venetoclax 94 Prednisone 93 Pemetrexed 90

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05651282 2025-08-29

RESToRE

University of British Columbia

Phase 4 Active not recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡